您要查找的是不是:
- Objective To discuss the maintenance of hepatic artery and/or portal vein chemotherapy pump subcutaneously embedded after hepatoma excision. 目的探讨肝癌切除术后皮下植入肝动脉和/或门静脉化疗泵的维护。
- Prophylaxis of portal vein chemotherapy on the recurrence after resection of hepatocellular carcinoma with tumor thrombi in portal vein 门静脉化疗对合并癌栓的原发性肝癌术后复发的预防作用
- Clinical value of portal vein chemotherapy in treatnent of hepatocellular carcinoma with tumor thrombosis of main trunk of portal vein 门静脉灌注化疗治疗肝癌伴门静脉瘤栓的临床价值
- Portal vein chemotherapy in early stage in preventing postoperative cancer of the large intestine from transfering cancer of the liver 手术后早期门静脉化疗预防大肠癌肝转移
- The value of Roferon-A combined with hepatic artery chemoembolization and portal vein chemotherapy after radical resection in hepatocellular carcinoma for preventing recurrenc 干扰素联合肝动脉化疗栓塞和门静脉化疗对预防肝癌切除术后复发的价值
- portal vein chemotherapy 门静脉化疗
- Preliminary survival observation on purcutaneous portal vein chronomodulated chemotherapy on treatment of liver cancer. 肝癌经皮门静脉时辰化疗生存期的初步观察。
- Objective To explore the therapeutic effect of dual perfusion embolization and chemotherapy via hepatic artery and portal vein( combmation treatment) in the treatment of unresectable PHC. 目的探讨肝动脉、静脉双栓化疗对不能切除的原发性肝癌的治疗作用。
- Objective To evaluate the value of bilateral internal iliac artery (BIIA) and portal vein pump implantation chemotherapy(three pump chemotherapy,TPC) in preventing local recurrence and hepatic metastasis after radical operation of rectal carcinoma. 目的探讨双侧髂内动脉加门静脉置泵化学治疗(三泵化疗)预防直肠癌根治术后局部复发和肝脏转移的价值。
- After chemotherapy 6 (Dukes' B stage 2 and Dukes'C stage 4)of 12 portal vein blood positive patients and 6 (Dukes B stage 2 and Dukes C stage 4)of 10 peripheral blood patients turned to negative. 12例门脉血阳性病人化疗后转阴6例,其中DukesB期2例,C期4例; 10例外周血阳性病人转阴6例,其中B期2例,C期4例。
- Objective To explore the curative effect of double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma. 目的探讨肝动脉、门静脉双重插管区域灌注化疗在中晚期不能切除原发性肝癌应用方法及临床疗效。
- Objective To explore the therapeutic effect of dual perfusion embolization and chemotherapy via hepatic artery and portal vein ( combmation treatment) in the treatment of unresectable PHC. 目的探讨肝动脉、静脉双栓化疗对不能切除的原发性肝癌的治疗作用。
- Methods:Fifteen cases of advanced HCC with PVTT were treated by hepatectomy, thrombectomy of portal vein with THACE,and 5 of the 15 cases received postoperative chemotherapy via portal vein. 方法:15例伴有门静脉癌栓的巨块型肝癌,均采用切除原发癌灶并取尽癌栓治疗,其中5例患者留置门静脉化疗泵,术后2周行肝动脉化疗栓塞或联合门静脉化疗。
- Strategy of Therapy for Portal Vein Spongiform in Children. 小儿门静脉海绵样变治疗的思路。
- There were no tumor thrombi in the main portal vein. 门静脉主干内未及癌栓。
- Of or relating to the portal vein or the portal system. 门静脉门静脉的,门静脉系统的,与门静脉系统有关的
- Objective To analyze the clinical effect of bronchial arterial infusing and systemic vein chemotherapy on moderate and advanced lung cancer in old patients. 结论经导管支气管动脉灌注化疗疗法和全身静脉化疗相比能更有效地控制原发病灶,对老年晚期肺癌患者是一个有效的治疗方法。
- The color flow of the portal vein revealed no color,red,mosaic or filling defect. 结果 :pv内CDFI可显示本色、红色、混色或充盈缺损。
- MRI also suggested hepatic metastasis in 4 cases, portal vein invasion in 7 cases. MRI发现 4例肝转移 ,7例门静脉主干或分支受累。
- Results The main portal vein appearance was accordant with 3D CE MRP and direct x-ray portography in all cases. 结果3D CE mrp和直接门静脉造影显示门静脉主干的结果完全一致。